..,1 ..2, ..3
1 ,
, .
2.
2 , , . .
3 , , . .
: ..
(2,6--4-) -, [1, 2]. . , , . .
-02 (), - ProntoSIL-120-5--18 AQ DB-2003 ( 2×7,5 , 5 ). 40, ‑ 100 /. : . 20 . - 282 , . 9:1.
[3, 4, 5]. : , , , () , .
, (- 2--4-), , . 98,44 102,05%. 0,81 0,94% . 16,00 24,00 / R2=0,99964 y=1,0065*x-0,094. . ( ). , , . FDA USA [3].
|
|
, . , .
:
[1] .., .. 10 (5), 145-149 (2011)
[2] .., .., .. . 2 (4), 183-190 (2011)
[3] FDA (1994) Center for Drug Evaluation and Research. Reviewer Guidance: Validation of Chromatographic Methods, Rockville, MD.
[4] ICH (1995) International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Guideline for Industry. Text on Validation of Analytical Procedures (Q2A).
[5] ICH (1996) International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Guideline for Industry. Validation of Analytical Procedures: Methodology (Q2B).